and Extracts Inhibit the Proliferation and Migration of Prostate Cancer Cells.

: Prostate cancer is the second most harmful disease in men worldwide and the number of cases is increasing. Therefore, new natural agents with anticancer potential should be examined and the response of existing therapeutic drugs must be enhanced. and are two species that have been widely used in traditional medicine, but their effectiveness on cancer cells and their interaction with antineoplastic drugs have not been studied. The aim of this study was to evaluate the anticancer activity of methanolic root extract () and methanolic root extract and their effect, combined with enzalutamide, on prostate cancer cells. The study was conducted on a human fibroblast cell line, and on androgen-dependent (LNCaP) and androgen-independent (PC-3) prostate cancer cell lines. The cell viability was evaluated using a Trypan Blue exclusion test for 48 h, and the migration by a wound-healing assay for 24, 48, and 72 h. The results indicate that and were not cytotoxic at concentrations less than 1000 μg/mL in the human fibroblasts. and significantly reduced the viability and migration of prostate cancer cells in all concentrations evaluated. The antiproliferative effect of the extracts was higher in cancer cells than in normal cells. The enzalutamide decreased the cell viability in all concentrations tested (10-50 µM). The combination of the extracts and enzalutamide produced a greater effect on the inhibition of the proliferation and migration of cancer cells than the extracts alone, but not of the enzalutamide alone. The results indicate that and have an inhibitory effect on the viability and migration of prostate cancer cells and do not interfere with the enzalutamide anticancer effect. The data suggest that extracts may be a potential source of molecules for cancer treatment.